Evofem Biosciences Inc (EVFM): With the value of the buyer and the conv...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	2
Posts	62
Boards Moderated	0
Alias Born	03/02/2015

vncntbill

Re: None

Friday, 12/15/2023 8:43:17 AM

Friday, December 15, 2023 8:43:17 AM

With the value of the buyer and the conversion rate it puts the EVFM shares at around $0.36 not sure why they haven't gotten at least into the $0.20's. Looks like a no brainer at this level. Not huge but might be at least a double in 30-60 days

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent EVFM News

Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:14:53 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:14:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 02:05:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:26:38 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/25/2024 09:23:08 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 10:13:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:53:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:17:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:05:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 11:40:26 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:07:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2023 12:50:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:49:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 12:01:21 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/29/2023 08:00:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 08:30:17 PM
Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 08/18/2023 08:08:14 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/18/2023 08:05:30 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/15/2023 04:15:15 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:26:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:25:05 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/14/2023 09:24:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 09:29:01 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/03/2023 09:31:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:05:18 PM

More EVFM News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover